Moreover, we show that LS180 colon cancer cells that overexpress SXR are less sensitive to CPT-11 treatment compared to control cells, indicating that this transcription factor is involved in drug resistance, probably through CYP3A4, CYP3A5, MDR1 and MRP1 upregulation. Here, CYP3A5 is linked to malignant colon neoplasm.